Home / Brands / Generic Peptides / Generic Peptides HGH Frag 176-191 2 and 5 mg Research Vials
Generic Peptides HGH Frag 176-191 2 and 5 mg Research Vials
Generic Peptides HGH Frag 176-191 2 and 5 mg Research Vials
Generic Peptides

Generic Peptides HGH Frag 176-191 2 and 5 mg Research Vials

Injection · 2 mg · vial

Out of stock
$39.00

Generic Peptides HGH Frag 176-191 is the lipolytic C-terminal piece of human growth hormone, supplied as a lyophilized research powder in two vial sizes: 2 mg and 5 mg.

GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. HGH Frag 176-191 for sale with international shipping and dispatch within two business days after payment.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides HGH Frag 176-191 - 2 and 5 mg Research Vials

Generic Peptides HGH Frag 176-191 is the C-terminal segment of human growth hormone, supplied as a lyophilized research powder in 2 mg and 5 mg vials. The peptide covers residues 176 to 191 of the hormone, the region that carries the lipolytic signal, and it is studied for fat mobilisation without the growth-promoting action of the full molecule. Its nearest relatives in this line are AOD-9604, a modified version of the same region, and the GHRH analog Tesamorelin.

  • Two vial sizes - 2 and 5 mg
  • Residues 176 to 191 of human growth hormone
  • Lyophilized powder
  • GMP-made, HPLC-verified, COA

Variant Comparison

Both vials hold the same fragment; only the amount of powder differs.

Variant Dosage Form and quantity Best use
HGH Frag 176-191 2 mg 2 mg Vial Short
HGH Frag 176-191 5 mg 5 mg Vial Extended

The 5 mg vial holds two and a half times the powder of the 2 mg vial and suits longer sampling runs, while the 2 mg size keeps material use low. The fat-vasculature peptidomimetic Adipotide and the direct hormone Somatropin are the usual companions when a lipolytic read-out is compared with a full growth hormone signal.

How HGH Frag 176-191 Works

The peptide is the 176 to 191 stretch of the growth hormone chain, a 16 amino acid sequence with a disulfide bridge and a mass near 1817 g/mol. That stretch is the part of the hormone linked to fat mobilisation in animal models, while the growth and glucose effects sit elsewhere in the molecule. It is not the same peptide as AOD-9604: AOD-9604 carries a tyrosine in place of the phenylalanine at the N-terminus, so the two are related but distinct research materials.

Reconstitution & Storage

Add bacteriostatic water down the wall of the vial and swirl, do not shake. Divide the milligrams on the vial by the millilitres added to read mg per mL: a 2 mg vial with 2 mL gives 1 mg/mL, so 0.1 mL on a U-100 syringe reads 100 mcg. Keep the sealed powder at 2-8 C or -20 C, protected from light, and the mixed solution at 2-8 C for about four weeks.

Dosage & Administration

No human dose is stated here and the vial is not a medicine. The native fragment has never been approved and has no clinical trials of its own in people, so nothing on this page is a treatment protocol or a dosing guide. HGH Frag 176-191 is named in WADA class S2.2.3 and is banned in sport at all times.

For laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use. HGH Frag 176-191 is supplied as a lyophilized powder and stays stable when the vial is kept cold, dry and out of light.

Specifications

Trade NameHGH Frag 176-191
Generic NameGrowth hormone peptide fragment 176-191
ManufacturerGeneric Peptides
Dosage2 mg or 5 mg per vial
PackageLyophilized powder, one vial
Drug ClassPeptide; growth hormone fragment
AdministrationSubcutaneous (research protocols)
StoragePowder at 2-8 C or -20 C, protect from light
Prescription StatusResearch use only
VerificationBatch details confirmed with supplier
ShippingInternational about USD 35; no USA option on this page

Stacks

Lipolytic Fragment Pair

HGH Frag 176-191 beside AOD-9604 in separate groups, the native sequence against the modified one with the tyrosine swap.

Expected outcome: a comparison of two closely related lipolytic fragments side by side.

Fragment And Full Hormone

HGH Frag 176-191 as the fat-only arm and Somatropin as the full hormone arm, held apart so the lipolytic signal is not mixed with the growth signal.

Expected outcome: a study that separates fat mobilisation from whole-hormone effects.

Three Fat Signals

HGH Frag 176-191 next to Adipotide and Tesamorelin, one fragment, one vessel-directed peptidomimetic and one GHRH analog.

Expected outcome: three fat-related read-outs from three different mechanisms.

For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

It is the segment of human growth hormone that runs from residue 176 to residue 191, a 16 amino acid peptide with the sequence Phe-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, a disulfide bridge and a mass near 1817 g/mol. That C-terminal stretch is the part linked to fat mobilisation in animal models, so it is supplied as a research material rather than a medicine.

No. Both come from the same fat-related region of growth hormone, but AOD-9604 carries a tyrosine where the native fragment has a phenylalanine at its N-terminus, and that single change makes them different molecules with different stability. Human lipolysis studies were run on AOD-9604, not on the unmodified 176-191 fragment, so the two should not be treated as interchangeable in any research plan.

No human safety data exist for the native fragment, so no label-based profile can be given. Injection-site reactions are common to the route. Long-term growth hormone signalling has been linked to effects on glucose and on the pituitary-thyroid axis, but for this fragment those remain unconfirmed. Treat it as an unstudied research material and handle it accordingly.

The fragment covers only the fat-related C-terminal region of growth hormone, and in animal models it did not carry the growth-promoting action of the whole molecule. It is studied precisely because that separation is of interest. No human study of the unmodified fragment has been published, so no statement about its effect on IGF-1 in people can be made from the available sources.

Add bacteriostatic water down the side of the vial and swirl, do not shake. Divide the milligrams on the vial by the millilitres added to read mg per mL: a 2 mg vial with 2 mL gives 1 mg/mL, so 0.1 mL on a U-100 syringe reads 100 mcg. Keep the sealed powder at 2-8 C or -20 C, protected from light, and the mixed solution at 2-8 C for about four weeks.

Yes. The WADA Prohibited List puts growth hormone fragments in class S2.2.3, inside the peptide hormone group S2, and substances in that category are prohibited at all times, in and out of competition. An athlete under anti-doping rules therefore cannot use this material at any point in the season. The current list is the only authority, since the classes are revised each year.

Both vial sizes are listed on this page as research material with international checkout. International shipping runs about 35 dollars with a transit window of four to ten days, and orders are handled within one to two business days. The U.S. domestic option is not open for this compound, so only the international route applies. Stock and prices are shown in the options above.

No reviews yet

Be the first to share your experience with Generic Peptides HGH Frag 176-191 2 and 5 mg Research Vials

Log in to write a review

Complete the cycle

Stack it with

View all